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Abstract: Patients with COPD may show slow, progressive deteriorations in arterial blood 
gases during the night, particularly during rapid eye movement (REM) sleep. This is mainly 
due to hypoventilation, while a deterioration of ventilation/perfusion mismatch plays a minor 
role. The severity of gas exchanges alterations is proportional to the degree of impairment 
of diurnal pulmonary function tests, particularly of partial pressure of oxygen (PaO2) and of 
carbon dioxide (PaCO2) in arterial blood, but correlations between diurnal and nocturnal blood 
gas levels are rather loose. Subjects with diurnal PaO2 of 60–70 mmHg are distinguished in 
“desaturators” and “nondesaturators” according to nocturnal oxyhemoglobin saturation behavior. 
The role of nocturnal hypoxemia as a determinant of alterations in sleep structure observed 
in COPD is dubious. Effects of the “desaturator” condition on pulmonary hemodynamics, 
evolution of diurnal blood gases, and life expectancy are also controversial. Conversely, it is 
generally accepted that occurrence of sleep apneas in COPD is associated with a worse evolu-
tion of the disease. Nocturnal polysomnographic monitoring in COPD is usually performed 
when coexistence of sleep apnea (“overlap syndrome”) is suspected, while in most other cases 
nocturnal oximetry may be enough. Nocturnal oxygen attenuates sleep desaturations among 
stable patients, without increases in PaCO2 of clinical concern. Nocturnal treatment with posi-
tive pressure ventilators may give beneﬁ  t to some stable hypercapnic subjects and patients with 
the overlap syndrome.
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Chronic obstructive pulmonary disease (COPD) is usually diagnosed in subjects with 
a clinical history of exposure to pulmonary risk factors who show a poorly reversible 
bronchial obstruction (NHLBI/WHO 2005). During wakefulness, abnormalities of 
respiratory function are demonstrated by standard pulmonary function tests (PFTs): 
among them, spirometry and arterial blood gas analysis are the most generally used 
to deﬁ  ne the degree of severity of COPD. A more complete evaluation of patients 
with this disease includes the assessment of sleep gas exchanges, which worsen to a 
variable extent with respect to wakefulness.
COPD is a high and increasingly prevalent disease. At present, its treatment only 
partially affects prognosis and quality of life. Our ability to predict prognosis of affected 
patients is improving (Celli et al 2004), but is still imperfect. A better knowledge of 
the aspect of respiratory function during sleep could probably improve our approach 
to the disease.
Features of sleep respiratory disorders in COPD
During sleep, minute ventilation physiologically decreases with respect to wakefulness 
(Douglas, White, Pickett, et al 1982), while pressure of oxygen in arterial blood (PaO2) 
falls and pressure of carbon dioxide (PaCO2) increases (Midgren and Hansson 1987). 
In healthy young subjects, as well as in many patients with respiratory diseases 
who are normoxemic while awake, the PaO2 reduction does not signiﬁ  cantly reduce 
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oxyhemoglobin saturation (SaO2). Instead, when PaO2 
is close to, or in, the steep portion of the oxyhemoglobin 
dissociation curve, SaO2 falls are common.
Likewise, in COPD diurnal PaO2 is correlated with noc-
turnal desaturations. In non-REM sleep, large SaO2 falls are 
uncommon, unless blood gas tensions during wakefulness 
are severely impaired. The most common ﬁ  nding is a small 
SaO2 reduction, while the breathing pattern remains sub-
stantially regular. Instead, prolonged oxygen desaturations 
are often observed throughout rapid eye movement (REM) 
sleep (Douglas et al 1979; Catterall et al 1983) (Figure 1). 
Long duration (often several minutes) and a slow resolution 
distinguish such desaturations from the typical desaturations 
of sleep apneas that rarely exceed a minute and are rapidly 
reverted (Bonsignore et al 1990). Prolonged hypoxemic 
episodes in REM sleep are not speciﬁ  c of COPD, but can 
also occur in other respiratory diseases (Becker et al 1999) 
and, to some extent, in healthy elderly subjects (Aber et al 
1989). Polygraphic signals recorded during such episodes 
do not always show well-deﬁ  ned alterations of ventilatory 
activity. They often suggest the occurrence of prolonged 
hypoventilation (Douglas et al 1979), or of hypopneas with 
either prevalent obstructive or central characteristics (White 
et al 1995). Irregularities of the breathing pattern, resembling 
those of normal subjects, often occur during phasic eye 
movement activity; they are characterized by short changes 
in depth and frequency of ventilation, and are often enough 
to cause some oxygen desaturation (George et al 1987).
Due to difﬁ  culties in monitoring, less information is 
available about PaCO2 changes. Invasive (Fletcher et al 1983; 
Catterall et al 1985), as well as transcutaneous (Midgren and 
Hansson 1987; Aubry et al 1989; O’Donoghue et al 2003), 
measurements showed a variable increase in PaCO2 during 
sleep that was proportional to PaCO2 during wakefulness 
(Aubry et al 1989; O’Donoghue et al 2003).
In some patients, COPD coexists with obstructive 
sleep apnea (OSA). This association is often referred 
to as “overlap syndrome” (Flenley 1985). Whether 
prevalence of OSA among patients with COPD is 
higher than (Chaouat et al 1995; Larsson et al 2001), or 
similar as (Sanders et al 2003; Bednarek et al 2005), in 
the general population is controversial. Differences in 
criteria of subjects’ recruitment may partly explain these 
contrasting results. In overlap patients, characteristics of 
sleep-disordered breathing (SDB) may resemble more 
those of OSA or of COPD, depending on which condition 
is preponderant.
Predictors of blood gas alterations 
during sleep
Among COPD patients, SaO2 values during sleep are 
signiﬁ  cantly correlated with diurnal values (Fleetham et al 
1982; Connaughton et al 1988; Vos et al 1995). For similar 
wake PaO2, desaturations tend to be worse in hypercapnic 
than in normocapnic subjects (Perez-Padilla et al 1987; 
Bradley et al 1990). This is in agreement with the early 
observations that desaturations during sleep are worse in 
“blue bloaters” than in “pink puffers” (Douglas et al 
1979; Catterall et al 1983). As long as blood gases during 
Figure 1 Recording of nocturnal oxyhemoglobin saturation during one night in a patient with COPD. Observe the prolonged desaturations during REM sleep stages.
Abbreviations: COPD, chronic obstructive pulmonary disease; REM, rapid eye movement; SaO2, oxyhemoglobin saturation. 
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wakefulness deteriorate in the natural course of the disease, 
nocturnal desaturations will deteriorate as well (Pépin et al 
1989). Ventilatory responses to hypoxia (Tatsumi et al 1986) 
and hypercapnia (Fleetham et al 1980; Tatsumi et al 1986; 
Vos et al 1995) during wakefulness are inversely correlated 
with desaturations during sleep, but it is not clear to what 
extent such correlations are independent of diurnal blood 
gas tensions. The importance of mechanical impairment as 
independent predictor of nocturnal desaturations is contro-
versial. One study found that inspiratory muscles strength 
was correlated to nocturnal SaO2, although its possible inﬂ  u-
ence was small as compared with that of PaO2 and forced 
expiratory volume in one second (FEV1) (Heijdra et al 1995). 
FEV1/forced vital capacity (FVC) was found to be a signiﬁ  -
cant predictor of sleep desaturations among patients with 
mild COPD (Sanders et al 2003). By contrast, other studies 
showed that any predictivity of FEV1 for sleep desaturations 
disappeared when blood gases were considered (Perez-Padilla 
et al 1987; Bradley et al 1990). 
Precise determination of nocturnal SaO2 has a different 
importance in patients with a different severity of the 
disease. In patients with normal or almost normal blood 
gas tensions during wakefulness, occurrence of signiﬁ  cant 
hypoxemia during sleep is unlikely, due to the correlation 
between diurnal PaO2 and nocturnal SaO2. In patients 
with severe hypoxemia during wakefulness, SaO2 shows 
a further reduction during sleep; its precise evaluation 
could induce to administer a higher oxygen ﬂ  ow in the 
nocturnal hours. In patients with mildly reduced PaO2 dur-
ing wakefulness, hypoxemia of some relevance may or may 
not occur during sleep. Therefore particular attention has 
been paid to subjects with diurnal PaO2 ranging between 
60 mmHg and 70 mmHg. Two criteria have been proposed 
to deﬁ  ne such patients as “desaturators”: a) a SaO2 fall 
below 90% lasting ≥5 minutes, with a nadir level ≤85% 
(Fletcher et al 1987); b) SaO2 values <90% for ≥30% of 
a whole nocturnal recording (Levi-Valensi et al 1990). 
Diurnal PaO2 and PaCO2 are worse in desaturators than 
Figure 2 Mechanisms leading to appearance or worsening of hypoxemia during REM sleep in COPD.
Abbreviations: COPD, chronic obstructive pulmonary disease; FRC, functional residual capacity; REM, rapid eye movement; PaO2, pressure of oxygen in arterial blood. 
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Table 1 Consequences of nocturnal hypoxemia and hypercapnia in COPD
 Acute  Chronic
Sleep   Altered sleep structure in severe   Worse sleep among pink puffers (mild    
structure  COPD, but inconsistent improvement   desaturators) than blue bloaters (severe    
  of sleep with O2 administration  desaturators)
Arrhythmias  Arrhythmias observed during severe   Danger of arrhythmias not directly    
  sleep desaturations and prevented by O2 administration  documented
Pulmonary   Increase in pulmonary artery   Inconsistent ﬁ  ndings about wake pulmonary  
artery pressure  pressure during sleep desaturations  artery pressure differences between    
   “desaturators”  and  “nondesaturators”
Diurnal blood gases    Similar wake blood gas evolution among    
    “desaturators” and “nondesaturators”;    
    possible worsening of blood gases in severe  
    patients suggested by beneﬁ  cial effects of   
   ventilatory  treatment 
Mortality  Death preferentially occurring at   Prognosis independent of nocturnal    
  night among patients with exacerbations  hypoxemia measured in stable conditions
Abbreviations: COPD, chronic obstructive pulmonary disease.
in nondesaturators, but only nocturnal instrumental 
monitoring allows us to reliably distinguish the two groups 
(Fletcher et al 1987).
Pathogenesis of hypoxemia 
during sleep 
Physiological modifications of respiratory control and 
muscular activity occurring during sleep do not result in 
hypoxemia in most normal subjects. In COPD patients, similar 
modiﬁ  cations interfere with the respiratory function alterations 
typical of the disease, and may lead to appearance or worsening 
of hypoxemia and hypercapnia.
Some deterioration of gas tensions may be already 
observed before sleep when assuming a recumbent posture, 
which causes a reduction in functional residual capacity (FRC) 
and, possibly, an increase in closing volume. 
Cough reflex is lost with sleep onset (Sullivan et al 
1979), which facilitates mucus accumulation in the airway, 
and enhances ventilation/perfusion mismatch throughout the 
whole sleep time.
In non-REM sleep the decrease in minute ventilation is not 
usually responsible for marked modiﬁ  cations in gas tensions, 
while more signiﬁ  cant blood gas derangements occur during 
REM sleep (Figure 2).
In REM sleep, several factors can contribute to reduce 
alveolar ventilation. In this sleep state, respiratory activ-
ity relies almost exclusively on the diaphragm, while the 
activity of intercostal (Tabachnik et al 1981) and accessory 
muscles (Johnson and Remmers 1984) ceases. As in COPD 
the efﬁ  ciency of diaphragmatic contraction is impaired, 
minute ventilation markedly decreases (Hudgel et al 1983; 
Ballard et al 1995). A decrease in minute ventilation may 
be favored by an increase in upper airway resistance and by 
a reduction in neuromuscular output (Ballard et al 1995). 
Ventilatory responsiveness to chemical stimuli physiologi-
cally decreases in REM sleep (Anthonisen and Kryger 1982; 
Douglas, White, Weil, et al 1982), which may be of particular 
concern in subjects whose responsiveness is already low 
during wakefulness. Eventually, bursts of rapid shallow 
breathing frequently occur, mainly in coincidence with eye 
movements (George et al 1987), and may cause an increase 
in ventilation of the dead space with a decrease in alveolar 
ventilation.
Invasive cardiorespiratory measurements during sleep 
suggested an important contribution of increased ventilation/
perfusion mismatch during REM sleep to nocturnal hypoxemia 
in COPD (Fletcher et al 1983); however, the real signiﬁ  cance 
of such measurements was later questioned, as they were 
performed in non steadystate conditions (Catterall et al 1985). 
Theoretically, an increased ventilation/perfusion mismatch 
could follow loss of accessory inspiratory muscles activity 
(Johnson and Remmers 1984), causing a decrease in FRC and 
an increase in closing volume. Noninvasive measurements 
performed by inductive plethysmography suggested that FRC International Journal of COPD 2006:1(4) 367
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could decrease during at least part of REM sleep (Hudgel et al 
1983). Later, measurements performed in hyperinﬂ  ated COPD 
subjects by means of body plethysmography in association 
with esophageal pressure ruled out this possibility (Ballard 
et al 1995); this suggests that, in COPD, hyperinﬂ  ation persists 
during REM sleep due to loss of elastic lung recoil, despite 
loss of accessory muscle activity.
In summary, hypoventilation, secondary to the sleep state, 
is the most important determinant of REM-related hypoxemia 
in COPD patients. Some contribution of an increased ventila-
tion/perfusion mismatch cannot be ruled out, but has not been 
clearly demonstrated. Nocturnal hypoxemia worsens along 
with the functional respiratory impairment, and particularly 
with deterioration of arterial blood gas tensions. The shape 
of the hemoglobin dissociation curve from oxygen accounts 
for the more marked drops in SaO2 among the subjects with 
diurnal hypoxemia.
Consequences of sleep respiratory 
disorders
Potential dangers of nocturnal hypoventilation episodes and 
of the associated hypoxemia in COPD are still uncertain 
(Table 1).
In patients with severe COPD, sleep structure is usually 
characterized by prevalence of light non-REM sleep stages 
and frequent arousals (Brezinova et al 1982). Such alterations 
were not present in patients with mild COPD with no coexist-
ent apneas (Sanders et al 2003). Arousals were correlated to 
oxygenation during sleep in one study (Cormick et al 1986), 
and hypoxemic episodes were suspected to be responsible for 
sleep alterations. However, despite lower nocturnal SaO2 in 
“blue bloaters” than in “pink puffers”, sleep quality evaluated 
by electroencephalogram (EEG) was not better in the latter 
group (Calverley et al 1982); besides, oxygen administration 
increased sleep duration in some experiences (Goldstein et al 
1984; Aubry et al 1989), but proved ineffective at improving 
sleep structure or duration in other studies (Fleetham et al 
1982; McKeon et al 1989; Lin 1996). A comparison between 
effects of oxygen alone, which improved nocturnal SaO2, and 
oxygen plus ventilatory treatment, which improved both SaO2 
and transcutaneous PaCO2, showed that the latter led to a sig-
niﬁ  cantly greater improvement in sleep duration (Meecham 
Jones et al 1995): that supports a previous hypothesis that 
PaCO2 affects sleep quality more than oxygen tension 
(Fleetham et al 1982). Treatment by lung volume reduction 
surgery improved at the same time nocturnal oxygenation 
and sleep structure, but changes in sleep quality were not 
correlated to those in nocturnal oxygenation (Krachman 
et al 2005). Subjective reports conﬁ  rmed that sleep quality 
is worse in COPD than in normal subjects. According to one 
study symptoms like cough or wheezing, and not degree of 
airway obstruction, are correlated to subjective sleep distur-
bances (Klink et al 1994), while another study pointed out 
the importance of comorbidities like depression or arthritis 
(Bellia et al 2003).
Hypoxemia during sleep enhances cardiac arrhythmias, 
at least when it is severe (Shepard et al 1985). Oxygen 
administration reduces nocturnal arrhythmias (Tirlapur and 
Mir 1982). It is unknown if such arrhythmias may inﬂ  uence 
life expectancy.
Hemodynamic monitoring during sleep in COPD showed 
that pulmonary arterial pressure (PAP) increases during 
hypoxemic episodes (Coccagna et al 1978; Boysen et al 
1979; Fletcher et al 1984), and that oxygen administration 
prevents at the same time desaturations and PAP augmen-
tations (Boysen et al 1979; Fletcher et al 1984). Whether 
or not desaturations occurring only during sleep in COPD 
are followed by a stable deterioration of pulmonary hemo-
dynamics is still debated. Fletcher and colleagues (1989), 
who adopted the ﬁ  rst deﬁ  nition for “desaturator”, reported 
above, observed higher PAP values among desaturators 
than nondesaturators, and a better evolution of diurnal 
PAP among desaturators receiving, than among those not 
receiving, nocturnal oxygen (Fletcher et al 1992). When the 
second deﬁ  nition was used, cross-sectional studies showed 
either higher (Levi Valensi et al 1992) or similar (Chaouat 
et al 1997) PAP values among desaturators, while later 
longitudinal investigations demonstrated no inﬂ  uence of the 
“desaturator” condition (Chaouat et al 2001) and of oxygen 
administration (Chaouat et al 1999) on PAP. Rasche and 
colleagues (2001) reported that PAP during wakefulness 
was signiﬁ  cantly correlated with lowest nocturnal SaO2, but 
not with time spent below 90% SaO2. 
It has been hypothesized that nocturnal hypoventilation 
may inﬂ  uence wake arterial blood gases. In subjects with 
mild diurnal hypoxemia, Chaouat and colleagues (2001) 
did not observe any trend toward a worse evolution of wake 
arterial blood gas tensions among desaturators than nonde-
saturators. By contrast, in subjects with chronic hypercapnic 
respiratory failure, prevention of nocturnal hypoventilation 
by ventilatory treatment was followed by an improvement in 
diurnal blood gases (Elliott et al 1992; Meecham Jones et al 
1995; Sivasothy et al 1998). The relatively mild nocturnal 
hypoxemia in the patients of the ﬁ  rst study, as opposed to the International Journal of COPD 2006:1(4) 368
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marked desaturations recorded in the others, could account 
for these apparently contrasting results. 
The most important consequence of nocturnal hypoventi-
lation could be a reduced life expectancy. Early observations 
on COPD patients hospitalized for exacerbation pointed 
out that death during hospital stay occurred preferentially 
in the nocturnal hours, suggesting that hypoxemia during 
sleep could immediately inﬂ  uence survival (McNicholas 
and Fitzgerald 1984). A later multicentre study on patients 
on long-term oxygen therapy, evaluated retrospectively, 
pointed out that nocturnal death does not often occur during 
sleep (Zielinski et al 1997). Besides, in other studies noc-
turnal hypoxemia did not show any independent role on the 
evolution of the disease (Connaughton et al 1988; Chaouat 
et al 2001). 
Consequences of nocturnal SDB are much worse and 
clearer in the overlap syndrome. COPD and OSA, when 
associated, are of particular concern: they have a synergistic 
effect, often leading to impairment of diurnal arterial blood 
gases and to stable pulmonary hypertension that would not 
be warranted by the degree of severity of each of the diseases 
taken alone (Bradley et al 1986; Chaouat et al 1995). 
Monitoring of nocturnal respiratory 
function
Nocturnal monitoring in COPD is performed to look for 
appearance of SDB, or to quantify worsening of blood gas 
exchanges during sleep and optimize treatment.
Polysomnography is a complex procedure consisting 
of simultaneous recording of sleep and cardio-respiratory 
parameters, and is usually performed throughout the night. It 
can detect disorders of ventilation and hypoxemic episodes, 
and allows us to temporally correlate them with sleep stages. 
Due to its high cost, its use must be limited. Theoretically, 
polysomnography is the most accurate method to explore 
nocturnal respiratory function, as it allows us to recognize 
possible underestimations of the usual degree of hypoxemia 
due to occasional lack of REM sleep during nocturnal monitor-
ing. However, it has been shown that oxygen desaturations, 
as explored during polysomnography, are less than resulting 
from simple oximetry monitoring, due to poor tolerability 
of the polysomnographic equipment, and to a shorter sleep 
during polysomnographic than oximetry monitoring (Brijker 
et al 2001). Today, in patients with COPD polysomnography 
is mainly performed when the coexistence of OSA is sus-
pected, due to symptoms like heavy snoring and excessive 
daytime sleepiness, or to fatigue, pulmonary hypertension or 
polycythemia out of proportion to the diurnal PFTs alterations 
(Kushida et al 2005).
Oximetry is inexpensive, and easy to perform and to 
tolerate. Modern instruments can be applied for prolonged 
ambulatory monitoring, keeping in memory consecutive 
diurnal and nocturnal data. Severity of hypoxemia and need 
of oxygen treatment may appear quite different when SaO2 
values recorded during diurnal rest and activity, as well as 
during the night, are taken into account at the same time, 
than when just instantaneous PaO2 at rest and SaO2 during 
exercise are considered (Sliwinski et al 1994; Pilling and 
Cutaia 1999; Fussell et al 2003). As regards SaO2 monitoring 
during sleep, today simple oximetry tends to be preferred 
over polysomnography in most COPD patients. Mean and 
lowest nocturnal levels, and time spent below 90% or 85% 
values are SaO2 measurements most commonly performed. 
Mean SaO2 is quite reproducible. Time spent below 90% is 
probably the most generally considered SaO2 parameter, as it 
is used to distinguish patients with mild diurnal hypoxia into 
desaturators and nondesaturators (Levi-Valensi et al 1990); 
however, it is highly variable between nights, suggesting that 
it may be appropriate to record oximetry for multiple, rather 
than for a single night (Lewis 2003).
Treatment of sleep respiratory 
disorders
In COPD exacerbations, a worsening in gas exchanges during 
sleep must be expected; mechanical ventilation is required 
(Lightowler et al 2003), but there are no guidelines taking into 
account nocturnal blood gas exchanges for such treatment in 
this condition.
So far, most studies on respiration during sleep in COPD 
have regarded patients in a clinically stable state. In such pa-
tients, treatment of nocturnal hypoxia may consist of drugs, 
oxygen, or mechanical ventilation. 
Little importance is usually attributed to drug treatment for 
hypoxemia during sleep in COPD. Among substances with 
bronchodilating effects, theophylline caused an improvement 
in hypoxemia, but sometimes at the expense of a worsening in 
sleep quality (Mulloy and McNicholas 1993); more recently, 
thiotropium bromide has been shown to determine some in-
crease in nocturnal SaO2 without interfering with sleep quality 
(McNicholas et al 2004). 
Oxygen and noninvasive ventilatory treatment correct 
more effectively nocturnal desaturations.
In stable hypoxic patients, oxygen is usually administered 
during part of the day and throughout the nocturnal hours International Journal of COPD 2006:1(4) 369
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(NOTT 1980; MRC 1981; NHLBI/WHO 2005). In clinically 
stable hypercapnic COPD patients without sleep apnea for 
whom long-term oxygen therapy (LTOT) was indicated, 
nocturnal oxygen administration at a ﬂ  ow rate sufﬁ  cient 
to ensure a diurnal SaO2 ≥90% prevented oxyhemoglobin 
desaturations, and caused a larger increase in transcutaneous 
PaCO2 than breathing room air (Goldstein et al 1984; Aubry 
et al 1989), not of clinical concern (Goldstein et al 1984). 
However, sleep desaturations are not always adequately cor-
rected by oxygen administered at that ﬂ  ow rate, especially 
in the most hypercapnic subjects (Plywaczewski et al 2000). 
What increase in oxygen ﬂ  ow is necessary in the nocturnal 
hours in patients on LTOT to prevent oxygen desaturation 
is not clear. It has been empirically proposed to increase 
oxygen ﬂ  ow at night by 1 liter/minute (ATS 1995), although 
an observation on a small number of patients suggested that 
a 0.5 liter/minute increase could be sufﬁ  cient (Servera et al 
1994). Nocturnal monitoring can be of help for the prescrip-
tion of the most appropriate nocturnal oxygen ﬂ  ow. 
In patients for whom LTOT is not indicated on the 
basis of the diurnal PaO2 level, advantages of nocturnal 
oxygen administration are still uncertain. The contrasting 
results about the effects on pulmonary hemodynamics of 
oxygen administered during the night for two or three years 
in desaturators have been mentioned above (Fletcher et al 
1992; Chaouat et al 1999). One study on a small number of 
subjects suggested that desaturators’ survival could beneﬁ  t 
from long-term nocturnal oxygen, although results were not 
statistically signiﬁ  cant (Fletcher et al 1992). However, a later 
study on a similar group of subjects could not ﬁ  nd any ef-
fect of nocturnal oxygen on either survival or deterioration 
in diurnal blood gases and delay in requirement of LTOT 
(Chaouat et al 1999).
Noninvasive nocturnal ventilatory treatment in stable 
COPD patients may be taken into account for some subjects 
with a severe form of the disease. Despite in these subjects 
hypoxemia is present during the whole day, in several cases me-
chanical ventilation may be applied only during the night, so as 
to correct the worst desaturations of the 24 hours, and not to in-
terfere with daily activities. Treatment is performed by positive 
pressure ventilators, more often by means of pressure support or 
by bilevel devices. If appropriately set, during their application 
SaO2 and PaCO2 levels can improve at the same time (Elliott 
et al 1992; Meecham-Jones et al 1995). In some subjects, noc-
turnal application of mechanical ventilation may be of beneﬁ  t 
also to diurnal blood gases after a few months (Elliott et al 1992; 
Meecham Jones et al 1995; Perrin et al 1997; Jones et al 1998; 
Sivasothy et al 1998; Clini et al 2002). Mechanisms of such 
improvement are not entirely clear. It is unlikely that inspira-
tory muscle rest has some responsibility. Some improvement in 
chemosensitivity to CO2 and in pulmonary mechanics, possibly 
due to reduced interstitial edema, could play a role (Elliott et al 
1991). On the average, compliance to, and beneﬁ  ts of, ventila-
tory treatment in COPD are less than in restrictive disorders 
(Leger et al 1994; Simonds and Elliott 1995). COPD patients 
to treat by mechanical ventilation must be carefully selected, 
must undergo a monitoring that demonstrates the efﬁ  cacy 
of the ventilator setting in correcting nocturnal hypoventila-
tion, and have to be adequately instructed and adapted to the 
ventilator use. Failure to fulﬁ  l some of these conditions may 
at least partly account for reports of unsuccessful trials with 
ventilatory treatment (Strumpf et al 1991; Gay et al 1996; Lin 
1996; Casanova et al 2000). It has been proposed to prescribe 
long-term ventilatory treatment in association with oxy-
gen administration to stable COPD subjects with symp-
toms suggestive of nocturnal hypoventilation (morning 
headache, apparently unwarranted fatigue or dyspnea) in 
one of the following conditions: a) a PaCO2 ≥55 mmHg; b) 
a PaCO2 ≥50 mmHg associated with recurrent hypercapnic 
respiratory failure; or c) a PaCO2 ≥50 mmHg associated with 
nocturnal SaO2 values ≤88% for at least 5 consecutive minutes 
despite oxygen administration at 2 liters/minute (CC 1999). 
In addition to effects on gas exchanges, ventilatory treat-
ment may be associated with an improvement in quality of 
life (Meecham-Jones et al 1995; Perrin 1997; Sivasothy et al 
1998; Clini et al 2002) and with a more prolonged nocturnal 
sleep, observed at polysomnography after a few months of 
treatment (Elliott et al 1992; Meecham-Jones et al 1995). An 
effect on survival and on number of exacerbations with an up 
to three-year treatment has not been demonstrated (Sivasothy 
et al 1998; Casanova et al 2000).
Indications and outcomes of mechanical ventilation are 
different in patients with the overlap syndrome. Due to the 
deleterious effects of the association of OSA to COPD, pre-
viously mentioned (Bradley et al 1986; Chaouat et al 1995), 
treatment by nocturnal ventilation must be performed in 
most of these patients. Continuous positive airway pressure 
(CPAP) is effective to eliminate obstructive apneas, but is not 
always enough to correct hypoxemia during sleep. Nocturnal 
monitoring can help us to decide if CPAP must be replaced 
by other kinds of ventilations (usually bilevel positive pres-
sure ventilation), and if it is necessary to associate oxygen 
administration with ventilatory treatment.International Journal of COPD 2006:1(4) 370
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Conclusions
Important questions remain unanswered several decades after 
studies on respiratory function in COPD began. In particular, 
the real danger represented by nocturnal oxygen desatura-
tions independently of diurnal blood gas levels, and the need 
to speciﬁ  cally address their treatment are still unclear. Most 
uncertainty comes from the correlation between diurnal and 
nocturnal blood gas levels that makes it difﬁ  cult to identify the 
separate effects of wake and sleep hypoxemia. To separately 
investigate the effects of sleep hypoxemia, many studies were 
done on patients with hypoxemia occurring only in the noc-
turnal hours: however, such patients often show sleep SaO2 
values only slightly below 90%, and for only part of the 
night. Negative results coming from such studies, rather than 
demonstrating lack of importance of nocturnal hypoxemia, 
could just indicate that moderate hypoxemia persisting only 
for a small portion of the 24 hours is of little concern. Severe 
nocturnal hypoxemia in patients with more advanced disease 
could be more dangerous, but its independent role is difﬁ  cult 
to demonstrate, as it is almost always associated with a degree 
of hypoxemia during wakefulness whose deleterious effects 
are already well known. As reported above, some studies 
on the effects of nocturnal ventilatory treatment in hyper-
capnic patients suggested that correction of nocturnal blood 
gases derangements is of beneﬁ  t, but positive results need 
to be conﬁ  rmed. So far, all trials on treatment of nocturnal 
hypoxemia, either by oxygen or by mechanical ventilation, 
have been based on small numbers of individuals. Current 
indications on treatment of nocturnal hypoxemia (ATS 1995; 
CC 1999) are based on a limited knowledge, and it is not 
surprising that the attitude of physicians towards oxygen pre-
scription for nocturnal hypoxemia remains variable (Wijkstra 
et al 2001). Long-term studies on large cohorts could help 
to give an answer to the still poorly known implications of 
SDB in COPD.
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